| scholarly article | Q13442814 |
| P50 | author | Renate Hammerstingl | Q64750031 |
| Thomas Joseph Vogl | Q2427883 | ||
| P2093 | author name string | Katrin Eichler | |
| Stefan Zangos | |||
| Jörn O Balzer | |||
| Tatjana Gruber | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 281-289 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study | |
| P478 | volume | 250 |
| Q64285139 | 3D Printed Absorber for Capturing Chemotherapy Drugs before They Spread through the Body |
| Q37867126 | Advances in regional chemotherapy of the liver |
| Q35843666 | CT Perfusion Imaging Can Predict Patients' Survival and Early Response to Transarterial Chemo-Lipiodol Infusion for Liver Metastases from Colorectal Cancers |
| Q35059732 | CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. |
| Q34330617 | Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies. |
| Q85010584 | Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol |
| Q64098705 | Colorectal liver metastases: An update on multidisciplinary approach |
| Q35095935 | Complications of loco-regional therapy in the liver-spectrum of imaging findings by CT and MRI |
| Q45133769 | Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study |
| Q35445092 | Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014 |
| Q83380321 | Curable metastatic colorectal cancer |
| Q64941039 | Current role of transarterial chemoembolization and radioembolization in the treatment of metastatic colorectal cancer. |
| Q38831025 | Current strategies in interventional oncology of colorectal liver metastases |
| Q37827492 | DC Bead embolic drug-eluting bead: clinical application in the locoregional treatment of tumours |
| Q39349619 | Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer-Y90 and Chemoembolization |
| Q27014926 | Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel |
| Q36076798 | Drug-eluting microspheres transarterial chemoembolization (DEM TACE) in patients with liver metastases. Pilot study. |
| Q59328910 | Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy |
| Q26752747 | Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases |
| Q36642970 | First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI). |
| Q37695686 | Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies |
| Q46020978 | Initial experience with repetitive transarterial chemoembolization (TACE) as a third line treatment of ovarian cancer metastasis to the liver: indications, outcomes and role in patient's management. |
| Q33587685 | Interventional procedures for hepatic metastases |
| Q31030760 | Interventional therapies of unresectable liver metastases |
| Q38179343 | Intra-arterial therapies for metastatic colorectal cancer |
| Q26784221 | Intrahepatic therapy for liver-dominant metastatic colorectal cancer |
| Q37353624 | Intravital microscopic research of microembolization with degradable starch microspheres |
| Q38206730 | Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review |
| Q35746556 | Locoregional therapy and systemic cetuximab to treat colorectal liver metastases |
| Q36392298 | Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data |
| Q38518842 | Minimal invasive treatments for liver malignancies |
| Q38398883 | Non-operative therapies for colorectal liver metastases |
| Q38685463 | Other non-surgical treatments for liver cancer |
| Q48346171 | Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under |
| Q37697312 | Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis |
| Q38014773 | Quality-improvement guidelines for hepatic transarterial chemoembolization |
| Q40121029 | Radiation dose to procedural personnel and patients from an X-ray volume imaging system |
| Q38813248 | Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial? |
| Q39455528 | Repetitive chemoembolization of hypovascular liver metastases from the most common primary sites |
| Q99713392 | The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis |
| Q92150490 | The role of interventional oncology in the treatment of colorectal cancer liver metastases |
| Q37357133 | Therapeutic effect and tolerability of gelatin sponge particle-mediated chemoembolization for colorectal liver metastases: a retrospective study |
| Q24234878 | Transarterial (chemo)embolisation for liver metastases |
| Q24197776 | Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases |
| Q24200851 | Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases |
| Q24202458 | Transarterial (chemo)embolisation versus other nonsurgical ablation methods for liver metastases |
| Q38488732 | Transarterial approaches to primary and secondary hepatic malignancies. |
| Q38531685 | Transarterial chemoembolization (TACE) for colorectal liver metastases--current status and critical review |
| Q46833149 | Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period |
| Q57283294 | Transarterial chemoembolization with raltitrexed-based or floxuridine-based chemotherapy for unresectable colorectal cancer liver metastasis |
| Q44027955 | Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population |
| Q37808643 | Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? |
| Q27003849 | Transcatheter embolization therapy in liver cancer: an update of clinical evidences |
Search more.